期刊文献+

cPLA2抑制剂对EGF和FBS诱导的Hela细胞增殖及cPLA2活性和蛋白表达的影响

Cytosolic phospholipase A_2 involved in epidermal growth factor and fetal bovine serum-induced proliferation in Hela cells and its activity and expression
下载PDF
导出
摘要 目的:研究抑制胞浆型磷脂酶A2(cPLA2)对表皮生长因子(EGF)和胎牛血清(FBS)诱导Hela细胞增殖及cPLA2活性和蛋白表达的影响。方法:采用cPLA2特异性抑制剂AACOCF3、反义寡核苷酸(SK7111)及其上游酶ERK1/2抑制剂U0126,分别作用于Hela细胞,观察在EGF及FBS作用下Hela细胞增殖以及细胞周期的变化;采用cPLA2活性检测盒及Western blot检测cPLA2活性及表达。结果:AACOCF3、SK7111及U0126均能明显抑制cPLA2活性,且呈剂量依赖性地抑制EGF和FBS诱导的Hela细胞增殖,尤以SK7111作用最为明显;流式细胞仪检测细胞周期表明,AACOCF3和U0126可将Hela细胞阻滞在S期。结论:cPLA2选择性抑制剂及其反义寡核苷酸可通过抑制cPLA2活性显著抑制EGF和FBS诱导Hela细胞增殖,同时,ERK1/2在此过程中可能具有调节作用。 Objective:To explore effects of cytosoloic phospholipase A2(cPLA2) on epidermal growth factor(EGF) induced and fetal bovine serum(FBS) induced Hela cells proliferation and its activity and expression.Methods:We used inhibitor AACOCF3 and antisense oligodeoxynucleotide(ODN) of cPLA2,and inhibitor U0126 of ERK1/2 to inhibit cPLA2 activity and expression,and observed the changes of Hela cells viabilities and cell cycle by CellTiter-Blue and flow cytometry.Meanwhile,cPLA2 activity and expression were also detected by cPLA2 activity assay kit and western blot.Results:Both inhibitor and antisense ODN of cPLA2 suppressed activity of cPLA2,and obviously inhibited the proliferation induced by EGF and FBS in dose-dependent manner in Hela cells.Both inhibitors of cPLA2 and ERK1/2 decreased cell proportion of G2/M obviously,and they blocked Hela at the S/G2 boundary.Moreover,the inhibitory effect on Hela cells proliferation of antisense ODN was most obvious and the inhibitory effect on cPLA2 protein expression was in a dose-dependent manner.The similar situation of ERK1/2 inhibitor was observed.Conclusion:cPLA2 could play important roles in EGF- and FBS-induced Hela cells proliferation,and ERK1/2 probably contribute to regulation on this course.
出处 《临床肿瘤学杂志》 CAS 2008年第10期865-870,共6页 Chinese Clinical Oncology
关键词 胞浆型磷脂酶A2 宫颈癌 增殖 表皮生长因子 细胞周期 Cytosolic phospholipase A2 Cervical cancer Proliferation Epidermal growth factor Cell cycle
  • 相关文献

参考文献12

  • 1Li Y, Wang Y, Jia C, et al. Detection of human papillomavirus genotypes with liquid bead microarray in cervical lesions of northern Chinese patients[ J]. Cancer Genet Cytogenet, 2008,182 (1) :12 -17.
  • 2Singh N, Jabeen T, Somvanshi RK, et al. Phospholipase A2 as a target protein for nonsteroidal anti-inflammatory drugs (NSAIDS): crystal structure of the complex formed between phospholipase A2 and oxyphenbutazone at 1.6 A resolution [ J ].Biochemistry, 2004,43 ( 46 ) : 14577 - 14583.
  • 3Laye JP, Gill JH. Phospholipase A2 expression in turoours: a target for therapeutic intervention? [ J ]. Drug Discov Today, 2003,8(15) :710 -716.
  • 4吴敏,李新国,张瑜.选择性COX-2抑制剂NS-398对宫颈癌细胞增殖和凋亡的影响[J].中国医学工程,2006,14(5):462-465. 被引量:2
  • 5Bruno IG, Jin W, Cote GJ. Correction of aberrant FGFR1 alternative RNA splicing through targeting of intronic regulatory elements [ J ]. Hum Mol Genet ,2004,13 ( 20 ) :2409 - 2420.
  • 6Rescan C, Le Bras S. EGF-induced proliferation of adult human pancreatic duct cells is mediated by the MEK/ERK cascade[ J]. Lab Invest ,2005,85 ( 1 ) :65 -74.
  • 7Tsou JH, Chang KY, Wang WC, et al. Nucleolin regulates c-Jun/Spl-dependent transcriptional activation of cPLA2 alpha in phorbol ester-treated non-small cell lung cancer A549 cells [ J ]. Nucleic Acids Res, 2008,36 ( 1 ) :217 - 227.
  • 8Xu L,Han C,Lim K,et al. Cross-talk between peroxisome proliferator-activated receptorδ and cytosotic phospholipase A (2) cyclooxygenase-2/prostaglandin E (2) signaling pathways in human hepatocellular carcinoma cells [ J ]. Cancer Res, 2006,66 (24) :11859 - 11868.
  • 9Boonstra J, van Rossum GS. The role of cytosolic phospholipase A2 in celt cycle progression[ J ]. Prog Cell Cycle Res, 2003,5: 181 - 190.
  • 10Sanchez T, Moreno JJ. The effect of high molecular phospholipase A2 inhibitors on 3T6 fibroblast proliferation [ J ]. Biochem Pharmacol,2001,61 ( 7 ) :811 - 816.

二级参考文献3

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部